Lynn Dressler, "Developing a personalized medicine program in a community hospital system: what’s ELSI got to do with it?"

Lynn Dressler, "Developing a personalized medicine program in a community hospital system: what’s ELSI got to do with it?"
Thursday, April 14, 2016 - 12:30 to 13:45

Lynn Dressler, Director of Personalized Medicine, Fullerton Genetics Center and Mission SECU Cancer Center, Mission Health, Asheville, NC, presents:

 

"Developing a personalized medicine program in a community hospital system: what’s ELSI got to do with it?"

Lunch Workshop, Thursday, April 14, 2016, CHHS 128, from 12:30-1:45

Lunch is included, but we need to know how much to order - so please RSVP here by Friday, April 8

 

Bio: Dr. Dressler joined Mission Health, in February 2013, to develop and direct the Personalized Medicine and Pharmacogenomics Program.   Formerly a faculty member in the Schools of Medicine and Pharmacy at the University of North Carolina at Chapel Hill, and a founding member of the UNC Institute for Pharmacogenomics and Individualized Therapy, Dressler’s 30 year career spans translational laboratory research in cancer, health policy research and the ethical ,legal, and social implications (ELSI) of genomic medicine.   Dressler holds a Master’s in Experimental Pathology, a doctorate in Health Policy and completed a fellowship in ELSI research.  At UNC, her laboratory conducted the research study that directly led to the FDA approval of the HER2 FISH assay (PathVYsion ™), one of the first pharmacogenomic tests in solid tumors.  In North Carolina, nearly 10 years prior to GINA, (Genetic Information Non Discrimination Act, Federal Statute), Dressler worked with the North Carolina General Assembly to pass a law to prohibit discrimination by employers and health insurance providers on the basis of an individual’s genetic information.  She has over 100 publications in related fields.

.

Cosponsored by the NC Biotech Center